Investigational Site

Saint Ann, Missouri 63074

0 studies enrolling now · 2 studies all time

What they study most

Anemia Associated With End Stage Renal Disease (ESRD), Anemia in Incident Dialysis Patients

Studies at this site

• Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants — Completed
• Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants — Completed